Form 10-Q aTYR PHARMA INC For: Sep 30

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/23/2026

1. DECK
2. RNG
3. WDC
4. BYD
5. WCN
6. SPOT
7. BMY
8. SPY
9. FIX
10. TSCO

Go back to Form 10-Q aTYR PHARMA INC For: Sep 30

aTyr Pharma (LIFE) Trims Q3 Loss

November 11, 2015 7:38 AM EST

aTyr Pharma (NASDAQ: LIFE) reported Q3 EPS of ($0.48), versus ($8.02) reported last year.

For earnings history and earnings-related data on aTyr Pharma (LIFE) click here.

... More

aTyr Pharma (LIFE) Selects iMod.Fc Molecule as IND Candidate

November 11, 2015 7:37 AM EST

aTyr Pharma (NASDAQ: LIFE) announced that it has selected an Investigational New Drug (IND) Candidate based on an immuno-modulatory and fibro-modulating Physiocrine domain fused to an Fc region of a human antibody, iMod.Fc. The selected iMod.Fc molecule is intended to address patients with severe pulmonary diseases with an immune and fibrotic component.

"The molecule developed in our iMod.Fc discovery program represents a major breakthrough as the first engineered Physiocrine with advantageous pharmaceutical properties... More